71 related articles for article (PubMed ID: 14660453)
1. Contrast sensitivity improves after brimonidine therapy in primary open angle glaucoma: a case for neuroprotection.
Evans DW; Hosking SL; Gherghel D; Bartlett JD
Br J Ophthalmol; 2003 Dec; 87(12):1463-5. PubMed ID: 14660453
[TBL] [Abstract][Full Text] [Related]
2. Randomised controlled trial comparing the effect of brimonidine and timolol on visual field loss after acute primary angle closure.
Aung T; Oen FT; Wong HT; Chan YH; Khoo BK; Liu YP; Ho CL; See J; Thean LH; Viswanathan AC; Seah SK; Chew PT
Br J Ophthalmol; 2004 Jan; 88(1):88-94. PubMed ID: 14693782
[TBL] [Abstract][Full Text] [Related]
3. Effect of brimonidine on retinal vascular autoregulation and short-term visual function in normal tension glaucoma.
Feke GT; Bex PJ; Taylor CP; Rhee DJ; Turalba AV; Chen TC; Wand M; Pasquale LR
Am J Ophthalmol; 2014 Jul; 158(1):105-112.e1. PubMed ID: 24709811
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of topical brimonidine-timolol for haemangioma of infancy and perils of off-label prescribing.
Chu MB; Searcy G; Siegfried E
BMJ Case Rep; 2013 Apr; 2013():. PubMed ID: 23598940
[TBL] [Abstract][Full Text] [Related]
5. Brimonidine Eye Drops within the Reach of Children: A Possible Foe.
Trotta D; Zucchelli M; Salladini C; Ballerini P; Rossi C; Aricò M
Children (Basel); 2024 Mar; 11(3):. PubMed ID: 38539352
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotection in Glaucoma: Basic Aspects and Clinical Relevance.
Kuo CY; Liu CJ
J Pers Med; 2022 Nov; 12(11):. PubMed ID: 36579616
[TBL] [Abstract][Full Text] [Related]
7. Analysing the change in contrast sensitivity post-travoprost treatment in primary open-angle glaucoma patients using Spaeth Richman contrast sensitivity test.
Ichhpujani P; Rodrigues AM; Kumar S; Singh RB
Int Ophthalmol; 2023 Jun; 43(6):2037-2047. PubMed ID: 36445547
[TBL] [Abstract][Full Text] [Related]
8. Barriers to IOP-independent treatments in glaucoma clinical trials.
Gherghel D; De Moraes G
Eye (Lond); 2023 Jul; 37(10):1955-1957. PubMed ID: 36400853
[No Abstract] [Full Text] [Related]
9. Triple Fixed-Combination Bimatoprost/Brimonidine/Timolol in Glaucoma and Ocular Hypertension in India: A Multicenter, Open-Label, Phase 3 Study.
Menon MG; Goodkin ML
Clin Ophthalmol; 2022; 16():3559-3569. PubMed ID: 36274674
[TBL] [Abstract][Full Text] [Related]
10. Alterations in Retinal Signaling Across Age and Sex in 3xTg Alzheimer's Disease Mice.
Frame G; Schuller A; Smith MA; Crish SD; Dengler-Crish CM
J Alzheimers Dis; 2022; 88(2):471-492. PubMed ID: 35599482
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotection in glaucoma.
Vishwaraj CR; Kavitha S; Venkatesh R; Shukla AG; Chandran P; Tripathi S
Indian J Ophthalmol; 2022 Feb; 70(2):380-385. PubMed ID: 35086201
[TBL] [Abstract][Full Text] [Related]
12. The Role of Adrenoceptors in the Retina.
Ruan Y; Böhmer T; Jiang S; Gericke A
Cells; 2020 Dec; 9(12):. PubMed ID: 33287335
[TBL] [Abstract][Full Text] [Related]
13. Can neuroprotection effectively manage primary open-angle glaucoma? a protocol of systematic review and meta-analysis.
Qi YX; Zhang J; Su XJ
Medicine (Baltimore); 2020 Jun; 99(23):e20380. PubMed ID: 32501982
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Contrast Sensitivity after Four Different Treatment Modalities Using OPTEC-Functional Vision Analyzer in Primary Open-Angle Glaucoma.
Azizzadeh P; Safarzadeh M
Middle East Afr J Ophthalmol; 2019; 26(2):60-64. PubMed ID: 31543661
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotection in Glaucoma: Old and New Promising Treatments.
Rusciano D; Pezzino S; Mutolo MG; Giannotti R; Librando A; Pescosolido N
Adv Pharmacol Sci; 2017; 2017():4320408. PubMed ID: 30723498
[TBL] [Abstract][Full Text] [Related]
16. A Masked, Randomized, Phase 3 Comparison of Triple Fixed-Combination Bimatoprost/Brimonidine/Timolol versus Fixed-Combination Brimonidine/Timolol for Lowering Intraocular Pressure.
Hartleben C; Parra JC; Batoosingh A; Bernstein P; Goodkin M
J Ophthalmol; 2017; 2017():4586763. PubMed ID: 29057117
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotection for treatment of glaucoma in adults.
Sena DF; Lindsley K
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD006539. PubMed ID: 28122126
[TBL] [Abstract][Full Text] [Related]
18. Non-amyloidogenic effects of α2 adrenergic agonists: implications for brimonidine-mediated neuroprotection.
Nizari S; Guo L; Davis BM; Normando EM; Galvao J; Turner LA; Bizrah M; Dehabadi M; Tian K; Cordeiro MF
Cell Death Dis; 2016 Dec; 7(12):e2514. PubMed ID: 27929541
[TBL] [Abstract][Full Text] [Related]
19. Role of cyclic AMP in the eye with glaucoma.
Shim MS; Kim KY; Ju WK
BMB Rep; 2017 Feb; 50(2):60-70. PubMed ID: 27916026
[TBL] [Abstract][Full Text] [Related]
20. Aqueous humor erythropoietin levels in open-angle glaucoma patients with and without TTR V30M familial amyloid polyneuropathy.
Beirão JM; Moreira LM; Oliveira JC; Menéres MJ; Pessoa BB; Matos ME; Costa PP; Torres PA; Beirão IB
Mol Vis; 2014; 20():970-6. PubMed ID: 25018619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
